Cure3 calls for artists to create an original piece of work in a Perspex cube – all in the name of Parkinson’s research. We find out more about the focus of this year’s fundraising exhibition
The third edition of the Cure3 exhibition, which raises money for UK charity Cure Parkinson’s Trust, brings together original artwork from 80 renowned international artists – and, in a special addition to this year’s event, creations from 11 fashion designers.
This year’s line-up sees top designers including Roksanda Ilinčić, Giles Deacon and Monika Dugar joining artists likeConrad Shawcross, Ron Arad, Rana Begum, Annie Morris and Idris Khan, in raising funding for Parkinson’s research.
The selling exhibition, which will take place from 5-8 September this year, challenges artists to create a new piece of artwork in a bespoke Perspex cube, which measures just 20cm3. This format is inspired by the ‘boxed in’ feeling of the condition, described by Cure Parkinson’s Trust founder, Tom Isaacs.
Since its launch in 2017, the project has raised more than £750,000. The Cure3 team hope to reach £1m of fundraising through artwork sales, alongside profits from a specially designed scarf created by heritage brand, Richard Allan London.
“It is about representing the hope that one-day we will be able to find a cure”
Some of the Cure3 artists cite a personal connection to the condition as a reason for taking part in the exhibition.
Award-winning designer Giles Deacon says: “I mainly work with charities that have a personal resonance and due to the fact that I have three close friends with Parkinson’s, it gives the initiative added meaning.”
Designer Giles Deacon, with his Cure3 cube.
Bouke de Vries, who specialises in ceramics and porcelain, says his partner’s Parkinson’s motivated him to take part: “Anything I can do to work towards a cure is my duty.”
Artist Mali Morris, who has designed a cube containing a colourful concertina of paper, created her piece in memory of her father, sister-in-law, and friend John McLean, who all had Parkinson’s.
Artist Mali Morris, with her design.
Other artists have created pieces inspired by the condition itself. “I began thinking about the cube and that I might make a coloured box of wool,” says contemporary artist and sculptor, Andy Goldsworthy. “I just grabbed a lump of fleece and rammed it into the box not really knowing what to expect. The transformation was extraordinary. It was like looking into another world. Afterwards I remembered that the farmer who owns the sheep around my home has Parkinson’s.”
Fashion designer Roksanda Ilinčić, took a different approach, working with textiles to reflect her thoughts on the future of Parkinson’s treatment.
“Using the specially designed print, the fabric has been moulded into the abstract shape of a brain to signify a perfectly functioning mind with all the creative thoughts and ideas represented through the contrasting colours and patterns. It is about representing the hope that one day we will be able to find a cure for Parkinson’s.”
Find out more about Cure3
For a limited time before the exhibition, some of the Cure3 artwork will be on display in the windows of London department store Fenwick. Cubes created for the exhibition will be available to buy on its website from 8am, 8 September and will also be displayed at Bonhams, an auction house in London, UK.
My PD Journey: landmark Parkinson’s summit highlights urgent need for new composite scale
European coalition set to roll out new and simple composite scale
3 weeks ago
Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award
Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…
Study explores predictors of cognitive impairment in Parkinson’s disease
Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.
Could frailty be a potential risk factor for Parkinson’s disease?
Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”